Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone
Author(s) -
Anthony J. Swerdlow,
Rosie Cooke,
Kerstin AlbertssonWikland,
Birgit Borgström,
Gary Butler,
Stefano Cianfarani,
Peter Clayton,
Joël Coste,
Annalisa Deodati,
Emmanuel Écosse,
Ruth Gausche,
Claudio Giacomozzi,
Wieland Kieß,
Anita C. S. HokkenKoelega,
Claudia E. Kuehni,
F Landier,
Marc Maes,
Primus-E. Mullis,
Roland Pfäffle,
Lars Sävendahl,
Grit Sommer,
Muriel Thomas,
Sally Tollerfield,
Gladys R.J. Zandwijken,
JeanClaude Carel
Publication year - 2015
Publication title -
hormone research in paediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.816
H-Index - 89
eISSN - 1663-2826
pISSN - 1663-2818
DOI - 10.1159/000435856
Subject(s) - cohort , medicine , incidence (geometry) , cohort study , cancer , population , oncology , pediatrics , environmental health , physics , optics
The long-term safety of growth hormone treatment is uncertain. Raised risks of death and certain cancers have been reported inconsistently, based on limited data or short-term follow-up by pharmaceutical companies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom